Marco Serafini

Marco obtained his Master’s Degree in Pharmaceutical Chemistry and Technology in 2020 from the University of Pisa, Italy. During his master thesis, he was involved in a project focused on drug discovery of new selective thyromimetics with potential therapeutic use, under the supervision of Prof. Simona Rapposelli and in collaboration with Dr. Sheraz Gul from the Fraunhofer Institute (ITMP, Hamburg, Germany). In 2021, he started his PhD at the Research Institute for Medicines (iMed), University of Lisbon, Portugal under the supervision of Prof. Rui Moreira and co-supervision of Prof. Alessio Ciulli. His doctoral studies are directed towards the design and development of novel PROTACs capable to induce specific intracellular degradation of Akt protein kinase for the treatment of cancer. He joined the Ciulli group as a PhD Visiting Student to carry out a six months research internship aimed at gaining further experience and skills in targeted protein degradation field.